This effect further highlights the anti-tumoral potential of adiponectin as high levels of CREB have been identified in prostate cancer, breast cancer, non-small-cell lung cancer (NSCLC), and leukemia and correlates with cancer cells differentiation and poor prognosis [39]. The gene discussed is CREB1; the disease is non-small cell lung carcinoma.